IOBT (IO Biotech, Inc.) Stock Financials & Earnings | Market Cap Arena

IOBT (IO Biotech, Inc.) Stock Financials & Earnings | Market Cap Arena

IOBTIO Biotech, Inc.

Mkt Cap$21M

Healthcare·Biotechnology·🇩🇰 Denmark·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$88M

EPS (TTM)-$1.35

Free Cash Flow (TTM)-$81M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q4 2025 · Mar 30

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	-$190K	-$20M
Q1 23	$0	-$174K	-$18M
Q2 23	$0	-$187K	-$22M
Q3 23	$0	-$194K	-$23M
Q4 23	$0	-$201K	-$28M
Q1 24	$0	-$211K	-$20M
Q2 24	$0	-$214K	-$22M
Q3 24	$0	-$205K	-$27M
Q4 24	$0	-$219K	-$27M
Q1 25	$0	-$227K	-$23M
Q2 25	$0	-$234K	-$23M
Q3 25	$0	-$230K	-$19M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$13M	-$13M
Q1 23	-$15M	-$15M
Q2 23	-$18M	-$18M
Q3 23	-$16M	-$16M
Q4 23	-$23M	-$23M
Q1 24	-$25M	-$25M
Q2 24	-$17M	-$17M
Q3 24	-$21M	-$21M
Q4 24	-$20M	-$20M
Q1 25	-$23M	-$23M
Q2 25	-$20M	-$20M
Q3 25	-$18M	-$18M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$349K
Q1 23	$148K
Q2 23	$39K
Q3 23	$24K
Q4 23	$112K
Q1 24	$11K
Q2 24	$12K
Q3 24	$10K
Q4 24	$11K
Q1 25	$28K
Q2 25	$26K
Q3 25	$4K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	—	-4.7%
Q1 23	—	+5.4%
Q2 23	—	+20.3%
Q3 23	—	+48.0%
Q4 23	—	+38.2%
Q1 24	—	+12.7%
Q2 24	—	-1.5%
Q3 24	—	+12.9%
Q4 24	—	-4.4%
Q1 25	—	+11.8%
Q2 25	—	+7.6%
Q3 25	—	-27.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$2M	—
Q1 23	$2M	—
Q2 23	$2M	—
Q3 23	$3M	—
Q4 23	$2M	—
Q1 24	$2M	—
Q2 24	$2M	—
Q3 24	$2M	—
Q4 24	$2M	—
Q1 25	$2M	—
Q2 25	$2M	—
Q3 25	$1M	—

OpEx Breakdown

Quarter	R&D	SG&A
Q4 22	$14M	$6M
Q1 23	$12M	$6M
Q2 23	$17M	$5M
Q3 23	$18M	$6M
Q4 23	$22M	$6M
Q1 24	$14M	$6M
Q2 24	$16M	$5M
Q3 24	$20M	$6M
Q4 24	$21M	$6M
Q1 25	$16M	$6M
Q2 25	$17M	$6M
Q3 25	$14M	$5M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$143M	$0	$143M
Q1 23	$129M	$0	$129M
Q2 23	$110M	$0	$110M
Q3 23	$166M	$0	$166M
Q4 23	$143M	$0	$143M
Q1 24	$118M	$0	$118M
Q2 24	$101M	$0	$101M
Q3 24	$80M	$0	$80M
Q4 24	$60M	$0	$60M
Q1 25	$37M	$0	$37M
Q2 25	$28M	$0	$28M
Q3 25	$31M	$0	$31M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	29M	+0.0%
Q1 23	29M	+0.0%
Q2 23	29M	+0.0%
Q3 23	50M	+74.1%
Q4 23	66M	+31.3%
Q1 24	66M	+0.0%
Q2 24	66M	+0.0%
Q3 24	66M	+0.0%
Q4 24	66M	+0.0%
Q1 25	66M	+0.0%
Q2 25	66M	+0.0%
Q3 25	67M	+1.6%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 19	—	—
FY 20	—	—
FY 21	$0	32
FY 22	$0	57
FY 23	$0	68
FY 24	$0	80